# Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma

> **NCT00979173** · PHASE1 · COMPLETED · sponsor: **Annick Desjardins** · enrollment: 5 (actual)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** AC480

## Key facts

- **NCT ID:** NCT00979173
- **Lead sponsor:** Annick Desjardins
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-10
- **Final completion:** 2012-06
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2014-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979173, "Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00979173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*